RxDoctor Payments Data

Tabitha Wolfson

Physician Assistant · Cedar Springs, MINPI 1346001161

Payments from drug & device makers

$1,548in general payments, 2019–2025

Across 71 payments — averaging $21.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$270
  • Novo Nordisk$168
  • AstraZeneca$142
  • Teva Pharmaceuticals USA, Inc.$129
  • Lilly USA, LLC$111
  • AbbVie$95
  • plus $633 from 16 others

What the payments were for

  • Food & beverage$1,548100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,548 in reported general payments places this provider in the 80th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin17$17,358
MounjaroTirzepatide16$16,845
OzempicSemaglutide12$15,023
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$8,580
Albuterol Sulfate HfaAlbuterol Sulfate43$1,407
Atorvastatin Calcium102$1,021
Levothyroxine Sodium46$615
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen20$582
Gabapentin26$572
Perphenazine11$540
Lisinopril60$494
Rosuvastatin Calcium23$478
Duloxetine Hcl17$407
Omeprazole37$362
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine11$325

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$111$16,84516 claims
Novo NordiskOzempic$168$15,02312 claims
GSKTrelegy Ellipta$31$8,58012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Cedar Springs

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →